Neurofeedback in children with attention-deficit/hyperactivity disorder (ADHD) – a controlled multicenter study of a non-pharmacological treatment approach

Table 1 Eligibility criteria

Inclusion criteria	Attention-deficit/hyperactivity disorder (combined type) (DSM-IV)
	Being 7 to 9 years of age
	Ability to understand character and individual consequences of the trial
	Written informed consent of the person with primary custody must be available before enrolment in the trial
Exclusion criteria	Diagnosis of bipolar disorder, psychosis, serious OCD, chronic serious tics or Tourette syndrome
	Major neurological or medical illness
	Pharmacotherapy for severe anxiety and mood disorders and psychosis
	Acute suicidal tendencies
	IQ below 80 (CPM)
	Non-German speaking child and primary caretaker
	No telephone
	Pregnancy and lactation
	Participation in other clinical trials and observation period of competing trials, respectively.

CPM Coloured Progressive Matrices, DSM-IV Diagnostic and Statistical Manual of Mental Disorders, version IV, OCD Obsessive Compulsive Disorder.

ISSN: 1471-2431